Advancing cardiovascular health - SignaCor Therapeutics lands €288k investment as pat of €1.1 million Seed round | EU-Startups

Belfast-based HealthTech startup SignaCor Therapeutics has raised €288k (£250k) in funding from VC firm Zinc in order to advance the development of a new treatment designed to repair heart damage and slow the progression of hypertrophic cardiomyopathy (HCM). Today’s investment is part of the winning package for being named the winner of Discovery Park’s startup […]